Andrew S. Moore

Queensland Children’s Hospital — Australia

Medicine · Health Sciences

39h-index11.4kcitations302works4.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(80), Acute Myeloid Leukemia Research(48), Glioma Diagnosis and Treatment(45), Childhood Cancer Survivors' Quality of Life(23), Cancer Genomics and Diagnostics(18)

Publications299 total

Integrated germline and somatic molecular profiling to detect cancer predisposition has a high clinical impact in poor-prognosis pediatric cancer
Clinical Cancer Research·2026
Population pharmacokinetics and dose–response relationships of mitoxantrone in children with acute myeloid leukaemia
British Journal of Clinical Pharmacology·2026Open Access
Fludarabine and cytarabine is not superior to high dose cytarabine as consolidation therapy in standard risk AML in children: Results from the international Phase III MyeChild01 trial
Blood·2025Open Access
Abstract A002-PR011: Precision Diagnosis in High-Risk Pediatric Oncology through Integrated Whole Genome, Transcriptome, and Epigenome Profiling
Cancer Research·2025
:<i>In the Shadow of Ebenezer: A Black Catholic Parish in the Age of Civil Rights and Vatican II</i>
The Journal of Religion·2025
Shakespeare and Machiavelli
2025
High Expression of <i>NTRK1</i> in <i>ETV6::RUNX1</i> Positive Acute Lymphoblastic Leukaemia Drives Factor Independence and Sensitivity to Larotrectinib
Pediatric Blood & Cancer·2025
Expanding the utility of transcriptome analysis for mutation detection in high-risk childhood precision oncology
2025Open Access
The 5’ fusion partner modulates response to the STAMP inhibitor asciminib in <i>ABL</i> -rearranged ALL
2025Open Access
Activity of STAMP inhibitors in ABL2 rearranged acute lymphoblastic leukemia is dependent on the Abl2 SH3 domain
Blood Neoplasia·2025· 2 citedOpen Access
Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced splicing factor-mutant myeloid malignancies
Leukemia·2025· 9 citedOpen Access
The Machiavellian Spectacle in Shakespeare’s Measure for Measure
Literature·2024Open Access
Pearling Drives Mitochondrial DNA Nucleoid Distribution
2024· 5 cited
Periodic ER-plasma membrane junctions support long-range Ca2+ signal integration in dendrites
Cell·2024· 38 cited
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years
Nature Communications·2024· 15 citedOpen Access
Structural dynamics of human ribosomes in situ reconstructed by exhaustive high-resolution template matching
Molecular Cell·2024· 12 citedOpen Access
Favourable Outcomes in Newly Diagnosed Paediatric AML with Gemtuzumab Ozogamicin and Risk-Stratified Therapy: Results from the International Phase III Myechild 01 Trial
Blood·2024· 4 citedOpen Access
Supplementary Table S21 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies &lt;i&gt;LMO2/STAG2&lt;/i&gt; Rearrangements as Extremely High Risk
2024Open Access
Supplementary Methods from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies &lt;i&gt;LMO2/STAG2&lt;/i&gt; Rearrangements as Extremely High Risk
2024Open Access
Supplementary Table S6 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies &lt;i&gt;LMO2/STAG2&lt;/i&gt; Rearrangements as Extremely High Risk
2024Open Access
page 1 of 15Next →

Frequent Co-authors

Ho‐Keung Ng(7), Jaume Mora(6), Alan Mackay(6), Diana Carvalho(6), Matthew Clarke(5), Chris Jones(5), Erika L.F. Holzbaur(5), Marc Remke(4), Wiesława Grajkowska(4), Alexandre Vasiljevic(4), Péter Hauser(4), Nada Jabado(4), Maryam Fouladi(4), Cláudia C. Faria(4), Cynthia Hawkins(4), Anna Burford(4), Maria Vinci(4), Sergey Popov(4), Valeria Molinari(4), Lynley V. Marshall(4)